• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement

    Pfizer Selects Seven Bridges to Support RNA Sequencing Data

    ACG Launches ACG Laboratories

    Glatt and Aprecia Enter 3D-Printing Collaboration

    Catalent Acquires Delphi Genetics
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions

    ACG Launches ACG Laboratories

    Glatt and Aprecia Enter 3D-Printing Collaboration

    Catalent Acquires Delphi Genetics

    Almac Group Completes $7M R&D Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing

    PwC Joins Medicines Manufacturing Innovation Centre

    AARDEX Group Partners with Pill Connect

    Phillips-Medsize and Subcuject Collaborate
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement

    Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions

    Pfizer Selects Seven Bridges to Support RNA Sequencing Data

    ACG Launches ACG Laboratories

    Catalent Acquires Delphi Genetics
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    PCI Pharma Services

    Almac Group

    Baxter BioPharma Solutions

    Reed-Lane

    Adare Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Adare Pharma Solutions

    Alcami

    Baxter BioPharma Solutions

    Syngene

    Emergent BioSolutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    Quality Management: Preserving and Perpetuating Your Record

    CDMOs must ensure that their top priority be delivering the highest quality products.

    Quality Management: Preserving and Perpetuating Your Record
    Colleen Herczak, Vice President of Quality, Grand River Aseptic Manufacturing01.28.20
    The pharmaceutical contract development and manufacturing market is expected to reach $126 billion by 2024 with the biologics segment expected to grow at the highest rate as there are more than 50 biologic U.S. patents set to expire in the next five years. It is clear that there is ample room to grow, yet not nearly enough discussion about how to do so responsibly.

    During periods of growth, contract development and manufacturing organizations (CDMOs) must take certain precautions to ensure that their top priority continues to be delivering the highest quality products to clients. Three important components to preserving a high-quality track record include strictly adhering to a process, making an unyielding commitment to professional development and acquiring the most efficient equipment.

    The earlier in the value stream that CDMOs can control the quality of a material, the better off they will be throughout the entire process. Extending their view of that value stream back to the raw materials received from vendors is the smart approach. Whether it is working with clients to identify preferred vendors or vetting new ones through supplier qualification programs, these comprehensive audits are indispensable to product purity. Regardless of increased throughput, these are critical first steps.

    Process validation—the next step—is also vital. It is not only how CDMOs develop a repeatable process for delivering reliable products, but also where the relationship between CDMO and sponsor is forged. The collaborative nature of this partnership, combined with the level of communication between the two organizations, considerably influences the quality of the end product. Both sides need to have a firm understanding of what is expected of them and the part they play at each stage of the process, from process design through continued process verification. After all, it is now our reputation that is at stake, and its safekeeping is a shared interest.

    As CDMOs grow, through consolidation or expansion, the stakes naturally raise along with heightened scrutiny, and it is pivotal to reassure clients and regulatory agencies that the quality of products will remain consistent. Transparency is the best form of reassurance, and this insight needs to reflect stability. For merging CDMOs, it could mean adopting one set of standard operating procedures over another, and for expanding organizations, it should mean keeping electronic systems as close to the same as possible while conserving a proportional level of investment in employee training programs.

    Employees are the lifeblood of any organization, and any investment in them fuels the efficiency of its operations. These investments are especially valuable to CDMOs as they relate to training new, and existing, employees at the senior management level. Leadership will find an indirect correlation between the time they spend training them and variability in their quality systems. With everyone working at the appropriate level, each employee is able to focus their full attention on delivering highly quality products, optimizing workforce productivity.

    To transfer this productivity and precision into a sustainable work product, complementary investments in technical competency are necessary. Effective digital capabilities that all CDMOs will want to consider include in-line monitoring of fill weights and real-time particulate monitoring, which allow for early detection and correction of potential issues. By streamlining these activities, CDMOs effectively mitigate error to the extent possible during manufacturing and testing—which can in turn deliver cost-savings to their pharmaceutical partners and give their operators opportunities to perform more complex projects that require human intervention.

    On the other hand, if CDMOs operate in the parenteral space, there will likely be additional expenditures in tools that remove human intervention as isolator technology has quickly become a prerequisite. With the growing need to formulate and fill more potent products aseptically, the industry has seen simultaneous growth in the use of this technology, despite its high price tag. The safety and sterility assurances it brings to operators and clients often outweigh its costs. And, given the extent to which isolator technology is customizable, it is uniquely fit for meeting the specific and varied needs of most CDMOs and their partners. There is no denying the return on investment it delivers or the value it adds through concurrent optimization of product integrity.

    Prioritizing the quality of products and investing heavily in employees and technology that ensure safety and reliability, is key. Also, training all employees to bring the highest-level of quality to every aspect of their work, is essential. 
    Related Searches
    • training
    • expansion
    • Parenteral
    • equipment

    Related Back Page

    • Aseptic Processing | Facilities | Fill/Finish | Parenterals
      The Future of Pharmaceutical Manufacturing

      The Future of Pharmaceutical Manufacturing

      Innovative multi-product facility and equipment design.
      Steve Nole, VP of Operations, Grand River Aseptic Manufacturing 01.27.21

    • Cell & Gene Therapy Supply Chain: Early Preparation is Key

      Cell & Gene Therapy Supply Chain: Early Preparation is Key

      Supply chain management for cell and gene therapies requires precise demand planning and forecasting.
      Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | R&D
      The Global Biotech Boom

      The Global Biotech Boom

      How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.
      Davide Garrisi, PPD Biotech 09.09.20


    • Speeding Vaccine Development with Advanced Analytics

      Speeding Vaccine Development with Advanced Analytics

      Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development process
      Dr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 05.05.20

    • APIs
      SOPs to Spur Growth in API Manufacturing

      SOPs to Spur Growth in API Manufacturing

      CMOs see outsourcing prospects improve
      S. Harachand, Contributing Editor 04.01.20

    • Trends Affecting the Generic Drugs Sector in 2020

      Trends Affecting the Generic Drugs Sector in 2020

      Supply chain issues, the need for additional talent chemists, lower drug prices, growth of development in the U.S. will be key factors.
      Ed Price, President, Seqens NA 03.04.20


    • Injectables
      Pitfalls to Avoid When Packaging Injectable Drug Products

      Pitfalls to Avoid When Packaging Injectable Drug Products

      Addressing legacy systems, lack of innovation adoption, and special challenges of New Molecular Entities.
      Fran DeGrazio, VP, Scientific Affairs and Technical Services, West Pharmaceutical Services 11.20.19

    • Information Technology
      Data Management in Life Sciences: Then and Now

      Data Management in Life Sciences: Then and Now

      A look at landmark changes in the management of data in the life sciences over the last 20 years and how the industry has addressed the challenges these develop
      Jason Lacombe, CEO, Veratrak 10.15.19

    • Clinical Trials | Information Technology
      Virtual Trials: Are they living up to their hype?

      Virtual Trials: Are they living up to their hype?

      This innovative approach is less costly, more patient-friendly, and delivers better quality data however, many stakeholders are still uncertain
      Josh Rose, VP R&D Global Strategy and Head of Virtual Trial Solutions, IQVIA 09.16.19


    • Avoiding Death by Spreadsheet

      Avoiding Death by Spreadsheet

      Cloud ERP systems are ushering in a new era of supply chain management
      Michael Kolias, QAD 06.13.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biotech Booms in the Yangtze River Valley

      Biotech Booms in the Yangtze River Valley

      A look at forces shaping the course of biotech growth in China
      Daniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19

    • India Eases Price Control  On Novel Drugs

      India Eases Price Control On Novel Drugs

      No price cap for innovator products for 5 years
      S. Harachand, Contributing Editor 03.06.19


    • Logistics | Supply Chain
      Pharma Distribution: Powering the Supply Chain Today & Shaping What’s Next

      Pharma Distribution: Powering the Supply Chain Today & Shaping What’s Next

      The role of pharmaceutical distributors in the increasingly complex supply chain
      Akin Odutola, AmerisourceBergen 01.25.19

    • Injectables | Parenterals
      Injectables Go Deeper

      Injectables Go Deeper

      Generic majors set sights on complex sterile injectables
      S. Harachand, Contributing Editor 11.14.18

    • Biologics, Proteins, Vaccines | Clinical Trials
      Getting to First-in-Human Clinical Trials

      Getting to First-in-Human Clinical Trials

      A make-or-break milestone for small biopharmas
      David Kenyon, Patheon 10.10.18

    Trending
    • Century Therapeutics Significantly Expands Capabilities
    • Catalent Acquires Delphi Genetics
    • Sanofi And Translate Bio Expand Vaccine Collaboration
    • RotaChrom Technologies Partners With Cyclolab
    • Wavelength Pharmaceuticals Acquires Majority Stake In Vanamali Organics
    Breaking News
    • Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    • Pfizer Selects Seven Bridges to Support RNA Sequencing Data
    • ACG Launches ACG Laboratories
    • Glatt and Aprecia Enter 3D-Printing Collaboration
    • Catalent Acquires Delphi Genetics
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    JRF Technology Debuts Elderberry Oral Film Strip
    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    Coatings World

    Latest Breaking News From Coatings World

    Hempel Launches Sustainability Framework: Futureproof
    ChemQuest Hires Rich Gibson
    New Increase in Kynar Fluoropolymer Capacities at Arkema's Chinese Site
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Previon, Spectrum Solutions Partner to Deliver At-Home COVID-19 Test
    NTT Research, Japanese Entity to Collaborate on Cardiovascular Disease Interventions
    Global Peripheral Intravenous Catheter Market to Reach $7.5 Billion by 2027
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    Pfizer Selects Seven Bridges to Support RNA Sequencing Data
    ACG Launches ACG Laboratories
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Afro Sheen Launches New Brand Initiatives
    Neopac Introduces Lightweight Plastic Tube
    Estée Lauder Companies Increases Investment in Deciem Beauty Group Inc.
    Happi

    Latest Breaking News From Happi

    PBA Opposes House Bill 2325 in West Virginia
    J.R. Watkins Tackles Pain with New Lines
    RB Launches Vanish Miracle
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Lowe-Martin Adds 2 KODAK NEXFINITY Digital Presses
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Eaglewood Technologies debuts new anilox cleaning system
    INX International and VerifyMe sign supply agreement
    Soma partners with DTM Flexo Services
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Fiber Bond VE3 Technology Inactivates SARS-CoV-2 in HVAC Filtration Systems
    Citizens Provides $325 Million Senior Credit Facility to Nice-Pak
    Ontex Reports Lower Revenues
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OrthoGrid Releases New Hip Replacement Software
    Nexus Spine Announces Availability of Spine Surgery Implants
    FDA OKs Brainlab's Loop-X Mobile Imaging Robot, Cirq Robotic Alignment Module
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    RFID Locks Market to Reach $9.93 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login